NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

49 hedge funds and large institutions have $36.6M invested in NeuBase Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 12 closing their positions.

Holders
49
Holders Change
-11
Holders Change %
-18.33%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
12
Reduced
18
Closed
12
Calls
$147K
Puts
$119K
Net Calls
+$28K
Net Calls Change
-$293K